regulation of type II interferon-mediated signaling pathway / HSP90-CDC37 chaperone complex / positive regulation of type 2 mitophagy / protein kinase regulator activity / protein folding chaperone complex / regulation of cyclin-dependent protein serine/threonine kinase activity / sperm mitochondrial sheath / sulfonylurea receptor binding / dATP binding / CTP binding ...regulation of type II interferon-mediated signaling pathway / HSP90-CDC37 chaperone complex / positive regulation of type 2 mitophagy / protein kinase regulator activity / protein folding chaperone complex / regulation of cyclin-dependent protein serine/threonine kinase activity / sperm mitochondrial sheath / sulfonylurea receptor binding / dATP binding / CTP binding / post-transcriptional regulation of gene expression / positive regulation of protein polymerization / vRNP Assembly / Scavenging by Class F Receptors / UTP binding / sperm plasma membrane / chaperone-mediated autophagy / Rho GDP-dissociation inhibitor binding / Respiratory syncytial virus genome replication / telomerase holoenzyme complex assembly / mitochondrial transport / Uptake and function of diphtheria toxin / protein insertion into mitochondrial outer membrane / Drug-mediated inhibition of ERBB2 signaling / Resistance of ERBB2 KD mutants to trastuzumab / Resistance of ERBB2 KD mutants to sapitinib / Resistance of ERBB2 KD mutants to tesevatinib / Resistance of ERBB2 KD mutants to neratinib / Resistance of ERBB2 KD mutants to osimertinib / Resistance of ERBB2 KD mutants to afatinib / Resistance of ERBB2 KD mutants to AEE788 / Resistance of ERBB2 KD mutants to lapatinib / Drug resistance in ERBB2 TMD/JMD mutants / regulation of type I interferon-mediated signaling pathway / TPR domain binding / PIWI-interacting RNA (piRNA) biogenesis / Assembly and release of respiratory syncytial virus (RSV) virions / non-chaperonin molecular chaperone ATPase / dendritic growth cone / Sema3A PAK dependent Axon repulsion / protein unfolding / positive regulation of cell size / regulation of protein ubiquitination / HSF1-dependent transactivation / response to unfolded protein / enzyme-substrate adaptor activity / skeletal muscle contraction / regulation of postsynaptic membrane neurotransmitter receptor levels / regulation of protein-containing complex assembly / HSF1 activation / telomere maintenance via telomerase / Attenuation phase / chaperone-mediated protein complex assembly / protein targeting / neurofibrillary tangle assembly / axonal growth cone / RHOBTB2 GTPase cycle / positive regulation of lamellipodium assembly / eNOS activation / nitric oxide metabolic process / Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation / DNA polymerase binding / heat shock protein binding / positive regulation of defense response to virus by host / response to salt stress / Signaling by ERBB2 / cardiac muscle cell apoptotic process / positive regulation of telomere maintenance via telomerase / endocytic vesicle lumen / positive regulation of cardiac muscle contraction / Loss of Nlp from mitotic centrosomes / Loss of proteins required for interphase microtubule organization from the centrosome / nitric-oxide synthase regulator activity / Recruitment of mitotic centrosome proteins and complexes / Recruitment of NuMA to mitotic centrosomes / activation of innate immune response / Anchoring of the basal body to the plasma membrane / lysosomal lumen / positive regulation of interferon-beta production / HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand / response to cold / ESR-mediated signaling / Constitutive Signaling by Overexpressed ERBB2 / protein tyrosine kinase binding / AURKA Activation by TPX2 / VEGFR2 mediated vascular permeability / Hsp90 protein binding / ATP-dependent protein folding chaperone / response to cocaine / Signaling by ERBB2 TMD/JMD mutants / brush border membrane / Constitutive Signaling by EGFRvIII / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / DDX58/IFIH1-mediated induction of interferon-alpha/beta / cellular response to virus / Regulation of actin dynamics for phagocytic cup formation / Regulation of necroptotic cell death / tau protein binding / VEGFA-VEGFR2 Pathway 類似検索 - 分子機能
THIS RESIDUE IS UNP DATABASE P07900 REF.1(CAA33259)
-
実験情報
-
実験
実験
手法: 溶液NMR 詳細: Structure of the human CDC37-HSP90 complex based on NMR using CSPs, RDCs and docking with HADDOCK
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
2D 1H-15N HSQC
1
2
2
3D 1H-15N NOESY
1
3
3
3D 1H-15N NOESY
1
4
1
IPAP(1H,15N)HSQC
1
5
1
IPAP(1H,15N)HSQC
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
0.8mM [U-100% 15N] human HSP90, 0.8mM [U-100% 15N] human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
2
0.8mM [U-100% 15N, U-100% 2H] human HSP90, 0.8mM human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
3
0.8mM human HSP90, 0.8mM [U-100% 15N, U-100% 2H] human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
0.8mM
humanHSP90
[U-100% 15N]
1
0.8mM
humanCDC37
[U-100% 15N]
1
50mM
HEPES
1
100mM
sodiumchloride
1
1mM
DTT
1
0.8mM
humanHSP90
[U-100% 15N, U-100% 2H]
2
0.8mM
humanCDC37
2
50mM
HEPES
2
100mM
sodiumchloride
2
1mM
DTT
2
0.8mM
humanHSP90
3
0.8mM
humanCDC37
[U-100% 15N, U-100% 2H]
3
50mM
HEPES
3
100mM
sodiumchloride
3
1mM
DTT
3
試料状態
イオン強度: 100 / pH: 7.4 / 圧: ambient / 温度: 298 K
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker Avance
Bruker
AVANCE
900
1
Bruker Avance
Bruker
AVANCE
800
2
Bruker Avance
Bruker
AVANCE
700
3
-
解析
NMR software
名称
バージョン
開発者
分類
TopSpin
2.1
BrukerBiospin
collection
TopSpin
2.1
BrukerBiospin
解析
Sparky
3.113
Goddard
データ解析
Sparky
3.113
Goddard
peakpicking
CARA
1.8.3
KellerandWuthrich
データ解析
CARA
1.8.3
KellerandWuthrich
peakpicking
CNS
1.1
Brunger, Adams, Clore, Gros, NilgesandRead
構造決定
CNS
1.1
Brunger, Adams, Clore, Gros, NilgesandRead
精密化
HADDOCK
2
A. Bonvin & C. Dominguez
geometryoptimization
HADDOCK
2
Dominguez, BoelensandBonvin
精密化
HADDOCK
2
A. Bonvin & C. Dominguez
構造決定
精密化
手法: simulated annealing, torsion angle dynamics / ソフトェア番号: 1 詳細: The structure was calculated using HADDOCK Details can be found in the jrnl citation above
代表構造
選択基準: best haddock score
NMRアンサンブル
コンフォーマー選択の基準: structures with the best HADDOCK scoring 計算したコンフォーマーの数: 200 / 登録したコンフォーマーの数: 10 / 代表コンフォーマー: 1